Heme oxygenase-1 gene therapy: a novel immunomodulatory approach in liver allograft recipients?

Transplant Proc. 2001 Feb-Mar;33(1-2):581-2. doi: 10.1016/s0041-1345(00)02151-5.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acute Disease
  • Animals
  • Genetic Therapy / methods*
  • Graft Rejection / genetics
  • Graft Rejection / immunology
  • Graft Rejection / therapy*
  • Heme Oxygenase (Decyclizing) / genetics*
  • Heme Oxygenase (Decyclizing) / metabolism
  • Heme Oxygenase-1
  • Interferon-gamma / metabolism
  • Interleukin-2 / metabolism
  • Liver Transplantation / immunology*
  • Male
  • Rats
  • Rats, Inbred Lew
  • Transplantation, Homologous
  • beta-Galactosidase / genetics
  • beta-Galactosidase / metabolism

Substances

  • Interleukin-2
  • Interferon-gamma
  • Heme Oxygenase (Decyclizing)
  • Heme Oxygenase-1
  • beta-Galactosidase